Article Details
Retrieved on: 2018-02-28 22:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Baupost Group</b> Llc/Ma owns $2.52 million in Orexigen Therapeutics, Inc., which represents roughly 11.87% of the company's market cap and approximately 31.45% of the institutional ownership. Similar statistics are true for the second largest owner, Glg Llc, which owns 1,524,143 shares of the stock are ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here